IBCSG's reply

[1]  G. Bonadonna,et al.  Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Anna L. Brown,et al.  Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B Fisher,et al.  Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  I. Tannock,et al.  A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Brazy,et al.  Unusual digestive lesions in a patient with Wilson's disease treated with long-term penicillamine. , 1985, The New England journal of medicine.

[6]  U. Bertazzoni,et al.  Philadelphia chromosome and TdT-positive AML. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Bonadonna,et al.  Long-term sequelae from adjuvant chemotherapy. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[8]  C. Osborne,et al.  Effects of Estrogens and Antiestrogens on Cell Proliferation , 1988 .